Structural

Patient Reported Outcomes in National Registries: Why and How?

22 min.

Why We Need a "Toolbox" Approach for the Tricuspid Valve

9 min.

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

17 min.

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

8 min.

The Compelling Case for Transcatheter Tricuspid Therapies

15 min.

Topline Results from the TRISCEND II Transcatheter Tricuspid Valve Replacement Trial

14 min.

Topline Results from the TRILUMINATE Transcatheter Tricuspid Edge-to-Edge Repair Trial

7 min.

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

11 min.

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

6 min.

RV Function and the Pulmonary Circulation: Physiological Insights Influencing Clinical Decision Making in TR Treatment

9 min.

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

7 min.

T-TEER - TRILUMINATE

7 min.

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

18 min.

Assessing Functional Status and Predicting Clinical Improvement

7 min.

Transcatheter Tricuspid Valve Replacement - TRISCEND II

7 min.

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

14 min.

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

13 min.

TRISCEND II: Understanding the Study Design and Interpreting the Results

8 min.

The Importance of Patient Reported Outcomes in TR Clinical Studies

14 min.

Experience-Based Lessons Learned from Real World T-TEER Cases

17 min.

Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives

15 min.

Pro-T-TEER: Safety Comes First, Risk of Replacement Outweighs the Benefits!

15 min.

Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes

7 min.

What Have the Studies Taught Us About Transcatheter Tricuspid Valve Replacement – The Good, the Bad, and the Ugly

13 min.

Can We Predict RV Failure After Tricuspid Intervention?

13 min.

Orthotopic TTVR: What Have We Learned From the EFS studies

14 min.

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

20 min.

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

22 min.

A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results

7 min.

One-Month Outcomes of the Multicenter TRAVEL II (Transvascular Tricuspid Valve Replacement with the LuX-Valve Plus System) Study

9 min.

The CROIVALVE Duo System for the Percutaneous Treatment of Tricuspid Regurgitation: Technology and Program Update

13 min.

Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)

12 min.

TRILUMINATE Pivotal Imaging Substudy: Insights from CT and MRI

13 min.

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

13 min.

PROs are a Powerful Endpoint in TR Interventional Trials

8 min.

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

18 min.

Current Clinical Evidence Following TR Interventions

20 min.

Case Resolution: A Patient With Severe TR and Limited Therapeutic Options

16 min.

First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM 1 Trial

13 min.

The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)

22 min.

First in Human Transfemoral TTVR with an Innovative Valve Replacement System (Topaz)

7 min.

The VDyne TTVR System: Early Human Clinical Results

17 min.

PASCAL T-TEER Clinical Trial Update (CLASP IITR)

7 min.

Combining the Best of Tricuspid Valve Repair & Replacement (CroiValve)

5 min.

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

7 min.

Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials

8 min.

Clinical Trial Data Supporting the Use of Tricuspid TEER in Symptomatic Severe TR Patients

8 min.

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

9 min.